J.-X. Zhou et al.
Bull. Chem. Soc. Jpn. Vol. 79, No. 4 (2006)
647
Ar-H), 7.48 (d, J ¼ 8:2 Hz, 2H, Ar-H), 7.73 (s, 1H, CH), 8.02
(d, J ¼ 8:0 Hz, 2H, Ar-H), 8.15 (d, J ¼ 8:6 Hz, 2H, Ar-H), 8.29
(d, J ¼ 8:4 Hz, 2H, Ar-H), 9.27 (s, 1H, NH); 13C NMR (DMSO-
d6, 75 MHz): ꢂ 20.71, 116.30, 117.76, 118.43, 120.63, 122.64,
126.83, 128.86, 129.92, 130.00, 137.17, 139.56, 141.81, 151.23,
162.38, 164.12; IR (KBr) 3301 (br, NH), 1608 (m, C=O), 1565,
1499, 1482, 1432 cmꢂ1; FABMS m=z (relative intensity) 430
(M þ 2, 15), 429 (M þ 1, 33), 428 (Mþ, 23), 155 (19), 154
(100), 138 (33), 137 (66), 136 (98). Anal. Calcd for C23H17Cl-
N6O: C, 64.41; H, 4.00; N, 10.60%. Found: C, 64.40; H, 4.04;
N, 10.63%.
2-{4-[4-(4-Ethoxyphenylamino)-2H-1,2,3-triazol-2-yl]phenyl}-
5-(4-methylphenyl)-1,3,4-oxadiazole (7c). The standard proce-
dure was followed to prepare 7c as a white powder in 83% yield:
mp 179–180 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 1.31 (t, J ¼
7:2 Hz, 3H, CH3), 2.48 (s, 3H, CH3), 3.99 (q, J ¼ 7:2 Hz, 2H,
CH2), 6.90 (d, J ¼ 8:8 Hz, 2H, Ar-H), 7.54 (d, J ¼ 9:0 Hz, 4H,
Ar-H), 7.68 (s, 1H, CH), 8.01 (d, J ¼ 8:7 Hz, 2H, Ar-H), 8.10 (d,
J ¼ 8:8 Hz, 2H, Ar-H), 8.24 (d, J ¼ 8:7 Hz, 2H, Ar-H), 9.09 (s,
1H, NH); 13C NMR (DMSO-d6, 75 MHz): ꢂ 15.19, 21.56, 63.59,
115.50, 117.72, 119.78, 120.34, 122.34, 126.32, 127.05, 128.65,
130.39, 137.79, 142.83, 143.18, 151.48, 153.32, 162.38, 164.12;
IR (KBr) 3400 (br, NH), 1613 (m, C=O), 1510 cmꢂ1; FABMS
m=z (relative intensity) 440 (M þ 2, 5), 439 (M þ 1, 19), 438
(Mþ, 24), 155 (19), 154 (23), 138 (8), 137 (14), 136 (23). Anal.
Calcd for C25H22N6O2: C, 68.48; H, 5.06; N, 19.17%. Found: C,
68.44; H, 5.06; N, 19.15%.
Fig. 3. Normalized photoluminescence spectra of 7h (blue
line: diluted in CH2Cl2 solution; red line: vacuum evapo-
rated film).
2-(4-Chlorophenyl)-5-{4-[4-(4-ethoxyphenylamino)-2H-1,2,3-
triazol-2-yl]phenyl}-1,3,4-oxadiazole (7d). The standard proce-
dure was followed to prepare 7d as a white powder in 82% yield:
mp 288–290 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 1.30 (t, J ¼ 7:2
Hz, 3H, CH3), 3.97 (q, J ¼ 7:2 Hz, 2H, CH2), 6.91 (d, J ¼ 8:8 Hz,
2H, Ar-H), 7.33 (d, J ¼ 8:8 Hz, 2H, Ar-H), 7.53 (d, J ¼ 9:0 Hz,
2H, Ar-H), 7.65 (s, 1H, CH), 8.04 (d, J ¼ 8:7 Hz, 2H, Ar-H),
8.08 (d, J ¼ 8:8 Hz, 2H, Ar-H), 8.23 (d, J ¼ 8:7 Hz, 2H, Ar-H),
9.10 (s, 1H, NH); 13C NMR (DMSO-d6, 75 MHz): ꢂ 17.35, 62.55,
115.39, 116.93, 117.22, 121.41, 124.63, 125.83, 126.90, 128.52,
129.75, 132.96, 136.29, 142.11, 152.43, 153.78, 163.84, 164.42;
IR (KBr) 3407 (br, NH), 1593 (m, C=O), 1426 cmꢂ1; FABMS m=z
(relative intensity) 460 (M þ 2, 6), 459 (M þ 1, 5), 458 (Mþ, 3),
155 (19), 154 (79), 138 (37), 137 (56), 136 (100). Anal. Calcd
for C24H19ClN6O2: C, 62.82; H, 4.17; N, 18.31%. Found: C,
62.91; H, 4.23; N, 18.29%.
2-{4-[4-(4-Fluorophenylamino)-2H-1,2,3-triazol-2-yl]phenyl}-
5-(4-methylphenyl)-1,3,4-oxadiazole (7e). The standard proce-
dure was followed to prepare 7e as a white powder in 82% yield:
mp 252–254 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 2.23 (s, 3H,
CH3), 7.25 (d, J ¼ 8:8 Hz, 2H, Ar-H), 7.49 (d, J ¼ 8:7 Hz, 2H, Ar-
H), 7.58 (d, J ¼ 8:4 Hz, 2H, Ar-H), 7.66 (s, 1H, CH), 8.07 (d,
J ¼ 8:2 Hz, 2H, Ar-H), 8.15 (d, J ¼ 8:2 Hz, 2H, Ar-H), 8.30 (d,
J ¼ 8:4 Hz, 2H, Ar-H), 9.42 (s, 1H, NH); 13C NMR (DMSO-d6,
75 MHz): ꢂ 116.25, 117.62, 118.39, 121.10, 122.18, 126.23,
127.36, 128.34, 129.33, 132.49, 133.28, 141.55, 142.93, 151.53,
164.09, 164.78; IR (KBr) 3309 (br, NH), 1606 (m, C=O), 1573,
1507, 1455 cmꢂ1; FABMS m=z (relative intensity) 414 (M þ 2,
22), 413 (M þ 1, 44), 412 (Mþ, 37), 155 (22), 154 (100), 138 (47),
137 (58), 136 (44). Anal. Calcd for C23H17FN6O: C, 66.98; H,
4.15; N, 20.38%. Found: C, 66.97; H, 4.17; N, 20.39%.
Fig. 4. Cyclic voltammogram of 7c in CH2Cl2 containing
0.1 M TBAPF6 at a scan rate of 50 mV sꢂ1
.
Standard Procedure of Dehydration–Cyclization (7a–7h).10
A solution of 4-[4-(4-substituted phenylamino)-2H-1,2,3-triazol-
2-yl]-N2-(4-substituted benzoyl)benzohydrazides (6a–6h, ꢁ230
mg) in POCl3 (10 mL) was stirred at 90 ꢃC for 10 h. After the re-
action was completed, cold water (10 mL) was added to the reac-
tion mixture, and the mixture was neutralized with a NaOH aque-
ous solution (10 mL) to precipitate the reaction product. The prod-
uct was washed with cold water (5 mL), filtrated and dried in a
vacuum oven overnight to give the desired product (7a–7h).
2-(4-Methylphenyl)-5-{4-[4-(4-methylphenylamino)-2H-1,2,3-
triazol-2-yl]phenyl}-1,3,4-oxadiazole (7a). The standard proce-
dure was followed to prepare 7a as a white powder in 85% yield:
mp 231–233 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 2.24 (s, 3H,
CH3), 2.41 (s, 3H, CH3), 7.12 (d, J ¼ 8:8 Hz, 2H, Ar-H), 7.40 (d,
J ¼ 8:8 Hz, 2H, Ar-H), 7.44 (d, J ¼ 8:0 Hz, 2H, Ar-H), 7.73 (s,
1H, CH), 8.02 (d, J ¼ 8:0 Hz, 2H, Ar-H), 8.12 (d, J ¼ 8:8 Hz, 2H,
Ar-H), 8.26 (d, J ¼ 8:8 Hz, 2H, Ar-H), 9.22 (s, 1H, NH); 13C NMR
(DMSO-d6, 75 MHz): ꢂ 116.55, 117.16, 118.73, 119.93, 121.64,
125.94, 127.37, 129.23, 132.13, 134.45, 138.16, 142.11, 152.47,
163.78, 164.12; IR (KBr) 3300 (br, NH), 1612 (m, C=O), 1567,
1494, 1432 cmꢂ1; FABMS m=z (relative intensity) 410 (M þ 2,
10), 409 (M þ 1, 64), 408 (Mþ, 48), 155 (19), 154 (94), 138 (33),
137 (51), 136 (100). Anal. Calcd for C24H20N6O: C, 70.57; H,
4.94; N, 20.57%. Found: C, 70.51; H, 4.99; N, 20.55%.
2-(4-Chlorophenyl)-5-{4-[4-(4-methylphenylamino)-2H-1,2,3-
triazol-2-yl]phenyl}-1,3,4-oxadiazole (7b). The standard proce-
dure was followed to prepare 7b as a white powder in 83% yield:
mp 229–231 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 2.25 (s, 3H,
CH3), 7.18 (d, J ¼ 8:4 Hz, 2H, Ar-H), 7.42 (d, J ¼ 8:6 Hz, 2H,
2-(4-Chlorophenyl)-5-{4-[4-(4-fluorophenylamino)-2H-1,2,3-
triazol-2-yl]phenyl}-1,3,4-oxadiazole (7f). The standard proce-
dure was followed to prepare 7f as a white powder in 88% yield:
mp 265–267 ꢃC; 1H NMR (DMSO-d6, 300 MHz) ꢂ 7.27 (d, J ¼